Kamada Meets Primary Endpoint of U.S. Phase 2 Study of Inhaled Alpha-1 Antitrypsin for the Treatment of Alpha-1 Antitrypsin ...
Company’s Inhaled AAT Demonstrated Significant Increase in Endothelial Lining Fluid Inhibitory Capacity Study Results Also Showed that Inhaled AAT is the Most Efficient Way of Delivering Therapeutic Amounts of AAT to the Primary Sites of Potential Lung …